New Federal Initiative Aims to Unravel Autism’s Origins
In a significant move, the National Institutes of Health (NIH) plans to harness the power of data from federal health insurance programs to probe the enigmas surrounding autism. This week, the agency revealed its strategy to develop a “real-world data platform” using information from Medicare and Medicaid to delve into the causes of autism.
The Department of Health and Human Services (HHS) has confirmed that the NIH will collaborate with the Centers for Medicare & Medicaid Services (CMS) to compile information from insurance claims, electronic medical records, and health-tracking wearables like smartwatches. HHS Secretary Robert F. Kennedy Jr. stated, “We’re using this partnership to uncover the root causes of autism and other chronic diseases.”
The data-sharing initiative will initially focus on individuals enrolled in Medicare and Medicaid—comprising about 36% of the U.S. population—and will track autism diagnoses before broadening the scope to other chronic conditions. “Using ASD [Autistic Spectrum Disorders] as the pilot research program, teams at CMS and NIH will establish a secure tech-enabled mechanism to enhance this data sharing with timely, privacy and security compliant data exchange,” read an HHS statement.
Despite assurances, the plan has sparked concerns over privacy. Last month, NIH Director Jay Bhattacharya faced backlash when he mentioned plans to compile a database of Americans with autism. However, HHS sources have clarified to various news outlets that this is not an effort to create a national autism registry.
Bhattacharya emphasized the partnership’s potential, stating, “Linking CMS claims data with a secure real-world NIH data platform, fully compliant with privacy and security laws, will unlock landmark research into the complex factors that drive autism and chronic disease — ultimately delivering superior health outcomes to the Americans we serve.”
Nonetheless, privacy advocates and the autistic community remain wary. Helen Tager-Flusberg, director of the Center for Autism Research at Boston University, highlighted the risks of potential data misuse: “CMS data includes certain information about individuals — age/date of birth, sex, where they live. It is possible to identify a person based on knowledge about these characteristics,” she stated in an email to NPR.
The heightened scrutiny on autism research coincides with Kennedy’s controversial assertions about the disorder’s origins, including debunked claims linking autism to vaccines and environmental toxins. Although he aims to identify autism’s cause by September, NIH Director Bhattacharya suggested a more realistic timeline of a year.
Recent findings from the Centers for Disease Control and Prevention indicate an increase in autism prevalence, likely due to improved screening methods. As the NIH and CMS embark on this new venture, the balance between groundbreaking research and privacy protection remains a focal point of public discussion.
